Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.2 Million CAD | -1293.51% |
| 2022 | 185.01 Thousand CAD | 108.3% |
| 2021 | -2.22 Million CAD | 80.72% |
| 2020 | -11.56 Million CAD | -11011.21% |
| 2019 | 105.97 Thousand USD | 199.05% |
| 2018 | -106.99 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 179.31 Thousand CAD | 135.76% |
| 2024 Q1 | -501.48 Thousand CAD | -179.78% |
| 2023 Q2 | -237.63 Thousand USD | 0.84% |
| 2023 Q1 | -239.64 Thousand CAD | -124.66% |
| 2023 FY | -2.2 Million CAD | -1293.51% |
| 2023 Q4 | -179.24 Thousand CAD | 88.75% |
| 2023 Q3 | -1.59 Million USD | -570.62% |
| 2022 Q3 | -209.61 Thousand CAD | -14.93% |
| 2022 Q2 | -182.37 Thousand CAD | 29.39% |
| 2022 Q1 | -258.29 Thousand CAD | 50.69% |
| 2022 FY | 185.01 Thousand CAD | 108.3% |
| 2022 Q4 | 971.98 Thousand CAD | 563.7% |
| 2021 Q2 | -589.12 Thousand CAD | 16.86% |
| 2021 Q3 | -419.2 Thousand CAD | 28.84% |
| 2021 Q4 | -523.84 Thousand CAD | -24.96% |
| 2021 FY | -2.22 Million CAD | 80.72% |
| 2021 Q1 | -708.59 Thousand CAD | -1291.62% |
| 2020 FY | -11.56 Million CAD | -11011.21% |
| 2020 Q4 | -50.91 Thousand CAD | -220.8% |
| 2020 Q3 | 42.15 Thousand CAD | -12.11% |
| 2020 Q2 | 47.95 Thousand CAD | -2.26% |
| 2020 Q1 | 49.06 Thousand CAD | 558.36% |
| 2019 Q2 | 123.67 Thousand CAD | 201.35% |
| 2019 Q4 | -10.7 Thousand CAD | -114.44% |
| 2019 Q1 | 41.04 Thousand CAD | 0.0% |
| 2019 Q3 | 74.11 Thousand CAD | -40.08% |
| 2019 FY | 105.97 Thousand USD | 199.05% |
| 2018 FY | -106.99 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -56.604% |
| Arrayit Corporation | -3.31 Million USD | 33.402% |
| Atlantic International Corp. | -5.62 Million USD | 60.763% |
| Biocept, Inc. | -32.08 Million USD | 93.118% |
| Bioqual, Inc. | 483.48 Thousand USD | 556.712% |
| CardioGenics Holdings Inc | -1.91 Million USD | -15.227% |
| DermTech, Inc. | -100.88 Million USD | 97.811% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.109% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 89.775% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1000.559% |
| IDenta Corp. | 14.64 Thousand USD | 15178.647% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 375.326% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 5807.351% |
| InVitro International | 1553.00 USD | 142283.967% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 74.3% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -3699.761% |
| Medical Imaging Corp. | -3.02 Million USD | 26.957% |
| NovelStem International Corp. | -4.18 Million USD | 47.266% |
| Optigenex Inc. | -2.89 Million USD | 23.799% |
| PharmChem, Inc. | 845.1 Thousand USD | 361.284% |
| Proteome Sciences plc | -2.44 Million USD | 9.615% |
| Response Genetics, Inc | -20.18 Million USD | 89.06% |
| Rennova Health, Inc. | -3.29 Million USD | 32.946% |
| RushNet, Inc. | -607.02 Thousand USD | -263.759% |
| ScreenPro Security Inc. | -2.24 Million USD | 1.808% |
| Stella Diagnostics Inc. | -5.7 Million USD | 61.312% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 80.657% |
| Todos Medical Ltd. | -24.99 Million USD | 91.165% |